Gore announces availability of septal occluder:
This article was originally published in Clinica
Executive Summary
W L Gore & Associates forecasts that its HELEX septal occluder device, recently launched in Europe, Australia and South America, could gain US marketing approval in around three years. The device, which is being studied under an investigational device exemption, has "significant advantages over [current]-devices", claims the Flagstaff, Arizona firm. When fully deployed, it takes on a double disc, rounded shape that minimises the risk of trauma to cardiac structures. It also incorporates a retrieval cord system that allows the device to be removed, even after it has been released from the catheter delivery system.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.